Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis.
about
Role and Function of A2A and A₃ Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis.Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors.Enhancement of CCL2 expression and monocyte migration by CCN1 in osteoblasts through inhibiting miR-518a-5p: implication of rheumatoid arthritis therapy.Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.Overexpression of microRNA-634 suppresses survival and matrix synthesis of human osteoarthritis chondrocytes by targeting PIK3R1Chondroprotective effect of high-molecular-weight hyaluronic acid on osteoarthritic chondrocytes in a co-cultivation inflammation model with M1 macrophagesVIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.Effects of Tribulus terrestris on monosodium iodoacetate‑induced osteoarthritis pain in rats.Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.ADAMTS16 mutations sensitize ovarian cancer cells to platinum-based chemotherapy.Histone deacetylase-4 and histone deacetylase-8 regulate interleukin-1β-induced cartilage catabolic degradation through MAPK/JNK and ERK pathways.The extracellular matrix-degrading protein ADAMTS5 is expressed in the nuclei of urothelial cells in healthy rats.CCN1 Promotes VEGF Production in Osteoblasts and Induces Endothelial Progenitor Cell Angiogenesis by Inhibiting miR-126 Expression in Rheumatoid Arthritis.Upper zone of growth plate and cartilage matrix associated protein protects cartilage during inflammatory arthritis.Effects of a 15-month anti-TNF-α treatment on plasma levels of glycosaminoglycans in women with rheumatoid arthritis
P2860
Q33624267-E48D9378-7C56-4AFB-A9D0-BC69F29E56B9Q33624763-A544ED6F-9FC3-462D-B769-E12FF81F1D36Q33673355-E8EA0B8A-3D36-4EED-BA71-7033346F8BFCQ33754764-37EE8F92-D8AB-4874-A633-02B4CE8906F0Q33925651-FEB251AF-3796-4BBC-8C38-89B1E68C50C2Q36682215-F9DA3B6C-21AB-462A-A3AB-F0B7BA17748BQ37251402-8B40B441-8685-487A-95DD-F32AC1420F8BQ37447842-17F90944-68C2-4BC2-940C-8C4A11121D35Q40076500-3EA0B0DB-C00C-447B-A73D-8EC78A3046B7Q41540301-78C5A8DF-BA76-4BF5-8596-495ABF2A22E4Q47135713-AC4651B1-EDF2-4392-98DC-1D0686D72668Q48515418-8FE1645F-91CE-4C3D-9EB4-FAF263F76B45Q50046209-7B6FB924-371B-41B5-BC69-B8E504AAC564Q51611747-0AEDEF8F-2A18-4EF7-98C1-2CC2F8E2148BQ55112360-9F851B03-7FB1-48F5-9897-0707CAF1B763Q58725170-C6D9A4D8-81D4-4A6F-9BA7-5B6053767776
P2860
Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Current and emerging therapeut ...... lage destruction in arthritis.
@en
type
label
Current and emerging therapeut ...... lage destruction in arthritis.
@en
prefLabel
Current and emerging therapeut ...... lage destruction in arthritis.
@en
P2860
P921
P1476
Current and emerging therapeut ...... lage destruction in arthritis.
@en
P2093
Carolyn M Dancevic
Daniel R McCulloch
P2860
P2888
P356
10.1186/S13075-014-0429-9
P5008
P577
2014-01-01T00:00:00Z
P5875
P6179
1048718512